Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ASPC | A Spac III Acquisition Corp. | $31.30 | $17.88 | 133.25% | 3.2M | $31M | $9.95$63.98 |
| GLSI | Greenwich LifeSciences | $20.88 | $3.67 | 21.32% | 486.8K | $238M | $7.78$20.94 |
| SIDU | Sidus Space | $2.62 | $0.42 | 19.09% | 122M | $78M | $0.63$6.75 |
| SHMD | Schmid Group | $5.91 | $0.89 | 17.73% | 298.8K | $244M | $1.86$6.70 |
| GSIT | Gsi Technology | $7.13 | $1.07 | 17.60% | 3.5M | $214M | $1.62$18.15 |
| PPSI | Pioneer Power Solutions | $4.73 | $0.68 | 16.67% | 953.3K | $45M | $2.25$5.70 |
| QBTZ | Tidal Trust II - Defiance Daily Target 2x Short Qbts ETF | $10.28 | $1.41 | 15.90% | 3.2M | - | $6.62$32.28 |
| EDAP | Edap Tms | $3.41 | $0.44 | 14.81% | 125 | $111M | $1.21$3.44 |
| SHIM | Shimmick | $3.27 | $0.42 | 14.74% | 110.4K | $102M | $1.30$3.50 |
| RAY | Raytech | $2.21 | $0.28 | 14.51% | 106.8K | $5.3M | $1.40$58.88 |
Related Articles
Featured Article
1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
Jia Jie Chen|Apr 21, 2021
The top-performing IPO of 2020 is a high-risk, high-reward opportunity, with one drug in its pipeline and one disease in its sights. Is it worth investing in now?
This Was the Top-Performing IPO in 2020
Rick Munarriz|Dec 28, 2020
A lot of buzz-generating IPOs have more than tripled in 2020, but you probably don't know the top U.S. debutante that has soared 583% this year.
Up 1,600% In 2 Days, Is It Too Late To Buy This Hot Biotech Stock?
Zhiyuan Sun|Dec 10, 2020
Greenwich LifeSciences made investors rich overnight. Is there any growth left in this breast cancer treatment developer?
Advertisement